Systems Analysis and Improvement to Optimize pMTCT
NCT02023658 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2017-01-26
Summary
Despite significant increases in global health investment and the availability of low-cost, efficacious interventions designed to reduce mother to child HIV transmission in low and middle income countries with high HIV burden, the translation of these scientific advances into effective delivery strategies has been slow, uneven and incomplete. As a result, pediatric HIV infection remains largely uncontrolled. Enhancing the implementation of pMTCT interventions through contextually appropriate systems analysis and improvement approaches can potentially reduce drop-offs along the pMTCT cascade, leading to dramatic improvements in infant and maternal outcomes. The goal of this proposal is to develop a model for systematic assessment and improvement of pMTCT services in sub-Saharan Africa. In specific aim 1, we will identify health system factors and service delivery approaches associated with high and low performing pMTCT services in Côte d'Ivoire, Kenya and Mozambique. In specific aim 2 we will adapt evaluate the feasibility and impact of a systems analysis tool and associated performance enhancement approach for pMTCT services in Côte d'Ivoire, Kenya and Mozambique. This systems analysis tool and associated performance enhancement approach is currently being developed and piloted for pMTCT services in Mozambique. The results of this implementation research are expected to generate knowledge of global health significance, and by disseminating the study results and intervention tools through the broad PEPFAR network, can rapidly impact pMTCT service delivery enhancements across the highest need countries.
Conditions
Interventions
- OTHER
-
pMTCT systems analysis and improvement
Five-step systems analysis and iterative improvement cycles carried out over a six-month period in intervention facilities.
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
collaborator NIH -
Network of AIDS Researchers of Eastern and Southern Africa
collaborator UNKNOWN -
Centro de Investigacao Operacional da Beira
collaborator UNKNOWN -
Health Alliance International
collaborator OTHER -
Eduardo Mondlane University
collaborator OTHER - lead OTHER
Principal Investigators
-
Kenneth Sherr, PhD · University of Washington
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- Côte d’Ivoire
- Kenya
- Mozambique
Study Locations
More Related Trials
-
The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria
NCT01936753 ·Status: COMPLETED ·Phase: NA
-
Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe
NCT02216734 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Population-level Impact of PMTCT Option B+ in Zimbabwe
NCT03388398 ·Status: COMPLETED
-
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
NCT00039741 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
NCT00334256 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Child Transmission of HIV in Malawi
NCT06493357 ·Status: RECRUITING ·Phase: NA
-
Point of Care Virologic Testing to Improve Outcomes of HIV-Infected Children
NCT02682810 ·Status: COMPLETED ·Phase: NA
-
Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
NCT00936195 ·Status: WITHDRAWN ·Phase: PHASE3
-
Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children
NCT00032669 ·Status: COMPLETED ·Phase: PHASE1
-
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIV
NCT06999928 ·Status: RECRUITING ·Phase: NA
-
Chinese Network of Pediatric Antiretroviral Therapy
NCT01210924 ·Status: COMPLETED
-
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
NCT00115648 ·Status: COMPLETED ·Phase: PHASE3
-
Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV
NCT00270296 ·Status: COMPLETED ·Phase: PHASE2
-
Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor
NCT00001826 ·Status: COMPLETED
-
Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania
NCT06605053 ·Status: RECRUITING ·Phase: NA
-
Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services
NCT02479659 ·Status: COMPLETED ·Phase: NA
-
Pediatric Enhanced Surveillance Study
NCT02043769 ·Status: COMPLETED
-
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578 ·Status: COMPLETED ·Phase: PHASE2
-
Long-Term Effects of HIV Exposure and Infection in Children
NCT00006304 ·Status: COMPLETED
-
Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP
NCT00204308 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
NCT01555723 ·Status: WITHDRAWN
-
Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
NCT00981695 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention
NCT03235310 ·Status: UNKNOWN
-
Early ART Initiation Among HIV-positive Pregnant Women in Central Mozambique
NCT02371265 ·Status: COMPLETED ·Phase: NA
-
Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya
NCT00427297 ·Status: TERMINATED ·Phase: PHASE3